Literature DB >> 26544767

Intraoperative mapping during repeat awake craniotomy reveals the functional plasticity of adult cortex.

Derek G Southwell1, Shawn L Hervey-Jumper1, David W Perry1, Mitchel S Berger1.   

Abstract

OBJECT To avoid iatrogenic injury during the removal of intrinsic cerebral neoplasms such as gliomas, direct electrical stimulation (DES) is used to identify cortical and subcortical white matter pathways critical for language, motor, and sensory function. When a patient undergoes more than 1 brain tumor resection as in the case of tumor recurrence, the use of DES provides an unusual opportunity to examine brain plasticity in the setting of neurological disease. METHODS The authors examined 561 consecutive cases in which patients underwent DES mapping during surgery forglioma resection. "Positive" and "negative" sites-discrete cortical regions where electrical stimulation did (positive) or did not (negative) produce transient sensory, motor, or language disturbance-were identified prior to tumor resection and documented by intraoperative photography for categorization into functional maps. In this group of 561 patients, 18 were identified who underwent repeat surgery in which 1 or more stimulation sites overlapped with those tested during the initial surgery. The authors compared intraoperative sensory, motor, or language mapping results between initial and repeat surgeries, and evaluated the clinical outcomes for these patients. RESULTS A total of 117 sites were tested for sensory (7 sites, 6.0%), motor (9 sites, 7.7%), or language (101 sites, 86.3%) function during both initial and repeat surgeries. The mean interval between surgical procedures was 4.1 years. During initial surgeries, 95 (81.2%) of 117 sites were found to be negative and 22 (18.8%) of 117 sites were found to be positive. During repeat surgeries, 103 (88.0%) of 117 sites were negative and 14 (12.0%) of 117 were positive. Of the 95 sites that were negative at the initial surgery, 94 (98.9%) were also negative at the repeat surgery, while 1 (1.1%) site was found to be positive. Of the 22 sites that were initially positive, 13 (59.1%) remained positive at repeat surgery, while 9 (40.9%) had become negative for function. Overall, 6 (33.3%) of 18 patients exhibited loss of function at 1 or more motor or language sites between surgeries. Loss of function at these sites was not associated with neurological impairment at the time of repeat surgery, suggesting that neurological function was preserved through neural circuit reorganization or activation of latent functional pathways. CONCLUSIONS The adult central nervous system reorganizes motor and language areas in patients with glioma. Ultimately, adult neural plasticity may help to preserve motor and language function in the presence of evolving structural lesions. The insight gained from this subset of patients has implications for our understanding of brain plasticity in clinical settings.

Entities:  

Keywords:  ADP = after-discharge potential; DES = direct electrical stimulation; FLAIR = fluid-attenuated inversion-recovery; GTR = gross-total resection; PET = positron emission tomography; STR = subtotal resection; TMS = transcranial magnetic stimulation; WHO = World Health Organization; awake craniotomy; brain plasticity; direct electrical stimulation; fMRI = functional MRI; glioma; surgical technique

Mesh:

Year:  2015        PMID: 26544767     DOI: 10.3171/2015.5.JNS142833

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  39 in total

1.  Spatial reorganisation of the somatosensory cortex in a patient with a low-grade glioma.

Authors:  Sunit Das; Melanie Morrison; Fred Tam; Simon Graham
Journal:  BMJ Case Rep       Date:  2019-05-05

2.  How many patients require brain mapping in an adult neuro-oncology service?

Authors:  Anastasios Giamouriadis; Jose Pedro Lavrador; Ranjeev Bhangoo; Keyoumars Ashkan; Francesco Vergani
Journal:  Neurosurg Rev       Date:  2019-05-19       Impact factor: 3.042

Review 3.  Brain connectomics applied to oncological neuroscience: from a traditional surgical strategy focusing on glioma topography to a meta-network approach.

Authors:  Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2021-02-09       Impact factor: 2.216

4.  The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.

Authors:  Anthony T Lee; Claire Faltermeier; Ramin A Morshed; Jacob S Young; Sofia Kakaizada; Claudia Valdivia; Anne M Findlay; Phiroz E Tarapore; Srikantan S Nagarajan; Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  J Neurosurg       Date:  2020-04-03       Impact factor: 5.115

5.  Impact of connectivity between the pars triangularis and orbitalis on identifying the frontal language area in patients with dominant frontal gliomas.

Authors:  Taiichi Saito; Yoshihiro Muragaki; Manabu Tamura; Takashi Maruyama; Masayuki Nitta; Shunsuke Tsuzuki; Takakazu Kawamata
Journal:  Neurosurg Rev       Date:  2018-11-10       Impact factor: 3.042

Review 6.  Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies.

Authors:  Chin-Hsing Annie Lin; Mitchel S Berger
Journal:  J Neurooncol       Date:  2019-12-18       Impact factor: 4.130

Review 7.  Functional MRI for Surgery of Gliomas.

Authors:  Antonella Castellano; Sara Cirillo; Lorenzo Bello; Marco Riva; Andrea Falini
Journal:  Curr Treat Options Neurol       Date:  2017-08-23       Impact factor: 3.598

Review 8.  Maximizing safe resection of low- and high-grade glioma.

Authors:  Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  J Neurooncol       Date:  2016-05-12       Impact factor: 4.130

Review 9.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 10.  Surgical oncology for gliomas: the state of the art.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Nat Rev Clin Oncol       Date:  2017-11-21       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.